At a time when the Maharashtra Government is struggling to meet the rising demand of Remdesivir vials despite repeated pleas to the Centre for increased supply, the Genetek Life Sciences on Thursday started production of these injections used in the treatment of COVID-19 in Wardha (Maharashtra).
Union Minister of Road and Highway transport Nitin Gadkari, who played a major role in getting necessary approvals, visited the company and inspected the production of Remdesivir vials. The company will produce 30,000 vials per day which will be distributed in Nagpur and other districts of Vidarbha and also rest of Maharashtra as per the requirement.
Gadkari said the commencement of production will address the shortage of Remdesivir injections. Similarly, it will be distributed in parts of Maharashtra as per the requirement and it will address the shortage of Remdesivir injections.
Hyderabad based Hetero Pharma had signed an agreement with Genetek Life Science in Wardha. The company had received a license to manufacture Remdesivir vials. A team from Hyderabad had reached Wardha and it was involved in the trials.
‘’If packaging is allowed in plastic bottles, production can increase up to two lakhs daily. This will provide great relief to the people of Maharashtra along with Nagpur and Vidarbha,’’ said Gadkari.